Secretory Component Glycoprote
in 抗体 [SRGP85]-Secretory Component Glycoprotein Antibody [SRGP85]- ￥22
- ProSci
- 美国
- PSI-33-914-100ug
- 2025年07月09日
- IF, IHC-P
- 小鼠
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
Recombinant human protein was used as the immunogen for the Secretory Component Glycoprotein antibody.
- 保存条件：
Aliquot and Store at 2-8℃
- 保质期：
1年
- 级别：
科研级别
- 库存：
100
- 供应商：
艾美捷科技
- 宿主：
小鼠
- 应用范围：
IF, IHC-P
- 抗体英文名：
Secretory Component Glycoprotein Antibody [SRGP85]
- 抗体名：
Secretory Component Glycoprotein Antibody [SRGP85]
- 规格：
100ug
Secretory Component Glycoprotein 抗体 [SRGP85]，Secretory Component Glycoprotein Antibody [SRGP85]，Secretory Component Glycoprotein 抗体 [SRGP85],Secretory Component Glycoprotein Antibody [SRGP85]
产品名称：Secretory Component Glycoprotein 抗体 [SRGP85]-Secretory Component Glycoprotein Antibody [SRGP85]
产品货号：PSI-33-914-100ug
产品规格：100ug
背景资料：Extracellular matrix protein 1 (ECM1), also called Secretory component p85, a soluble protein that is involved in endochondral bone formation, angiogenesis, and tumor biology. It also interacts with a variety of extracellular and structural proteins, contributing to the maintenance of skin integrity and homeostasis. Mutations in this gene are associated with lipoid proteinosis disorder (also known as hyalinosis cutis et mucosae or Urbach-Wiethe disease) that is characterized by generalized thickening of skin, mucosae and certain viscera. [RefSeq]
保存建议：Secretory Component Glycoprotein 抗体 [SRGP85]-Secretory Component Glycoprotein Antibody [SRGP85]Aliquot and Store at 2-8℃
应用类型：IF, IHC-P
点击：Secretory Component Glycoprotein 抗体 [SRGP85]-Secretory Component Glycoprotein Antibody [SRGP85]查看更详细产品说明，更多应用、储存、价格、货期等信息请垂询艾美捷科技有限公司。更多ProSci公司特色试剂盒、特色抗体以及特色试剂等产品评论，请点击查看艾美捷特色产品中心。
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Detection of the MDR1 P-Glycoprotein Expression and Function
Acquired and intrinsic multidrug resistance is the major reason for the failure of anticancer chemotherapy. The most important component of clinical multidrug resistance is mediated by P-glycoprotein (Pgp), an ABC transporter encoded
to the formation of active C1, which in turn activates the CCP in an immunoglobulin-dependent or -independent manner. C1q is a hexameric glycoprotein composed of 18 polypeptide chains of three different types (A, B, and C), organized in two fragments—collagen
Synchronizing Protein Transport in the Secretory Pathway
or transported to their target compartments, newly synthesized proteins leave the endoplasmic reticulum to reach the Golgi apparatus, where they are processed and sorted toward their final destinations along the secretory pathway. It is now clear that many Golgi
技术资料暂无技术资料 索取技术资料
